N-(5-氨基-2-甲基苯基)-4-(3-吡啶基)-2-氨基嘧啶
N-(5-Amino-2-methylphenyl)-4-(3-pyridyl)-2-pyrimidineamine;4-Methyl-N'-[4-(pyridin-3-yl)pyrimidin-2-yl]benzene-1,3-diamine;4-methyl-3-[4-(3-pyridyl)pyrimidin-2-ylamino]aniline;N-(2-Methyl-5-Amino Phenyl)-4-(3-Pyridyl)-2-Pyrimidine;4-Methyl-N3-[4-(3-Pyridinyl)-2-Pyrimidinyl]-1,3-Benzenediamine;N-(5-amino-2-methylphenyl)-4-(3-pyridinyl)-2-pydimidineamine;1,3-BENZENEDIAMINE,4-METHYL-N3-[4-(3-PYRIDINYL)-2-PYRIMIDINYL]-;6-Methyl-n1-[4-(pyridine-3-yl)pyrimidin-2-yl]benzene-1,3-diamine;2-(5-Amino-2-methylanilino)-4-(3-pyridyl)pyrimidine;6-Methyl-N1-(4-(pyridin-3-yl)pyrimidin-2-yl)benzene-1,3-diamine;C16H15N5;N-(5-AMINO-2-METHYL)-4-(3-PYRIDYL)-2-PYRIMIDIME AMINE;4-methyl-3-N-(4-pyridin-3-ylpyrimidin-2-yl)benzene-1,3-diamine;4-Methyl-N3-[4-(3-pyridyl)-2-pyrimidinyl]-1,3-phenylenediamine;N-(5-Amino-o-tolyl)-4-(3-pyridyl)-2-pyrimidinamine;4-Methyl-N3-[4-(pyridin-3-yl)pyrimidin-2-yl]-1,3-benzenediamine;IMatinib IMpurity C;Imatinib EP Impurity F;Imatinib USP Impurity F;IMatinib interMediates;(5,AMINO 2-MethylPHENYL) 4,(3,PYRIDYL) 2,PYRIMIDINEAMINE;152460-10-1;6-methyl-N1-[4-(pyridin-3-yl)pyrimidin-2-yl]benzene-1,3-diamine;6-METHYL-N1-[4-(PYRIDIN-3-YL)PYRIMIDIN-2-YL]BENZENE-1,3-DIAMINE;SY046834;1,3-Benzenediamine, 4-methyl-N3-(4-(3-pyridinyl)-2-pyrimidinyl)-;Q-100177;IMATINIB AMINE [USP IMPURITY];N-(5-amino-2-methylphenyl)-4-(3-pyridyl)-2-pyrimidine amine;6-Methyl-N1-(4-(pyridine-3-yl)pyrimidin-2-yl)benzene-1,2-diamine;Imatinib Mesilate Imprity F [EP IMPURITY];SCHEMBL2392;QGAIPGVQJVGBIA-UHFFFAOYSA-N;4-methyl-N3-[4-(3-piridinyl)-2-pirimidinyl]-1,3-benzendiamine;DS-0284;AC-2147;Imatinib amine [USP];1,3-Benzenediamine, 4-methyl-N3-[4-(3-pyridinyl)-2-pyrimidinyl]-;4-Methyl-N3-(4-(pyridin-3-yl)pyrimidin-2-yl)benzene-1,3-diamine;BDBM50287097;AKOS015888614;MFCD09028125;CS-W014568;Imatinib amine;N-(5-Amino-2-methylphenyl)-4-(3-pyridinyl)-2-pyrimidineamine;BCP22918;112GI007;SB60556;4-Methyl-N3-[4-(pyridin-3-yl)pyrimidin-2-yl]benzene-1,3-diamine;n-(2-methyl-5-aminophenyl)-4-(3-pyridyl)-2-pyrimidine amine;AM20050827;N-(5-amino-2-methylphenyl)-4-(3-pyridinyl)-2-pyrimidine-amine;VU0549314-1;DTXSID30433443;4-Methyl-N~3~-[4-(pyridin-3-yl)pyrimidin-2-yl]benzene-1,3-diamine;CCG-310976;4-Methyl-N*3*-(4-pyridin-3-yl-pyrimidin-2-yl)-benzene-1,3-diamine;CHEMBL278103;Imatinib Impurity F;FT-0696298;N-(5-Amino-2-methyl phenyl)-4-(3-pyridyl)-2-pyrimidineamine;6-Methyl-N1-[4-(3-pyridyl)-2-pyrimidinyl]-1,3-benzenediamine;N-(5-amino-2-methyl phenyl)-4-(3-pyridinyl)2-pyrimidine-amine;F9995-0188;Z1741977607;FT-0647597;4-methyl-N~3~-(4-pyridin-3-ylpyrimidin-2-yl)benzene-1,3-diamine;EN300-7372570;6-Methyl-N-(4-(pyridine-3-yl)pyrimidin-2-yl)benzene-1,3-diamine;UNII-JR9RZF7KDS;NS00077786;AC-619;N-(5-amino-2-methylphenyl)-4-(3-pyridyl)-2-pyrimidine-amine;VCC489937;6-methyl-N1-(4-(pyridin-3-yl)pyrimidin-2-yl)benzene-1,3-diamine;FT-0655675;JR9RZF7KDS;Imatinib impurity D